Product Category:
Detailed Information
Formoterol Fumarate Inhalation Solution
Kelishu®
Generic Name: Formoterol Fumarate Inhalation Solution
Indications: This product is indicated for the maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. The recommended dosage is twice daily (morning and evening) for long-term use.
Detailed Information
Lacosamide Oral Solution
Weigening®
Generic Name: Lacosamide Oral Solution
Indications: This product is indicated for the adjunctive treatment of partial-onset seizures in patients with epilepsy aged 4 years and above.
Detailed Information
Micafungin Sodium for Injection
Boruifenning®
Generic Name: Micafungin Sodium for Injection
Indications: For the treatment of the following fungal infections caused by Aspergillus and Candida: fungemia, respiratory fungal infections, and gastrointestinal fungal infections.
Detailed Information
Esomeprazole Magnesium for Delayed-release Oral Suspension
Yajin®
Generic Name: Esomeprazole Magnesium for Delayed-release Oral Suspension
Indications:
Gastroesophageal Reflux Disease (GERD)
-Treatment of reflux esophagitis
- Long-term maintenance therapy for healed esophagitis to prevent recurrence
-Symptom control in GERD
Helicobacter pylori Eradication:
-Combined with appropriate antibiotic therapy to:
-Heal H. pylori-associated duodenal ulcers
-Prevent recurrence of H. pylori-associated peptic ulcers
NSAID-associated Gastric Ulcer:
-Treatment of gastric ulcers in patients requiring continuous NSAID therapy
Detailed Information
Oseltamivir Phosphate Capsules
Puliaowei®
Generic Name: Oseltamivir Phosphate Capsules
Indications:(A) treatment of influenza A and B in adults and pediatric patients 1 year and older, to be initiated within 48 hours of symptom onset; (B) prophylaxis of influenza A and B in adults and adolescents 13 years and older.
Detailed Information
Argatroban Injection
Bomaitong®
Generic Name: Argatroban Injection
Indications:(1) improving neurological symptoms (e.g., motor paralysis) and activities of daily living (including walking, standing, sitting balance, and eating) in acute ischemic stroke patients within 48 hours of onset; (2) managing limb ulcers, rest pain and coldness in chronic arterial occlusion patients with thromboangiitis obliterans (Buerger's disease) or arteriosclerosis obliterans.
Semi rigid Cast
Nasal Spray
Dynamic intra-abdominal pressure monitoring
